Stuart Cobb
Chief Scientific Officer at Neurogene Inc. (NGNE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $141K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 17SEC | NGNENeurogene Inc. | Sell Plan | 3,99133,303 held (−11%) | $20.41 | $81K | +13.9% |
| Mar 17SEC | NGNENeurogene Inc. | Sell Plan | 2,65830,645 held (−8%) | $21.34 | $57K | +9.0% |
| Mar 17SEC | NGNENeurogene Inc. | Sell Plan | 14830,497 held (−0%) | $22.08 | $3K | +5.3% |
- Sell
Chief Scientific Officer Stuart Cobb sold $81K of NGNE at $20.41 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Stuart Cobb sold $57K of NGNE at $21.34 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Stuart Cobb sold $3K of NGNE at $22.08 — pre-scheduled 10b5-1 plan sale.